These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1285424)

  • 1. Myelin P0-protein, more than just a structural protein?
    Filbin MT; Tennekoon GI
    Bioessays; 1992 Aug; 14(8):541-7. PubMed ID: 1285424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant peripheral myelin protein P0 confers both adhesion and neurite outgrowth-promoting properties.
    Schneider-Schaulies J; von Brunn A; Schachner M
    J Neurosci Res; 1990 Nov; 27(3):286-97. PubMed ID: 1711125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization and functional roles of PMP22 in peripheral nerves of P0-deficient mice.
    Carenini S; Neuberg D; Schachner M; Suter U; Martini R
    Glia; 1999 Dec; 28(3):256-64. PubMed ID: 10559784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of myelin P0 protein as a homophilic adhesion molecule.
    Filbin MT; Walsh FS; Trapp BD; Pizzey JA; Tennekoon GI
    Nature; 1990 Apr; 344(6269):871-2. PubMed ID: 1691824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein zero is necessary for E-cadherin-mediated adherens junction formation in Schwann cells.
    Menichella DM; Arroyo EJ; Awatramani R; Xu T; Baron P; Vallat JM; Balsamo J; Lilien J; Scarlato G; Kamholz J; Scherer SS; Shy ME
    Mol Cell Neurosci; 2001 Dec; 18(6):606-18. PubMed ID: 11749037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P0 mRNA expression in cultures of Schwann cells and neurons that lack basal lamina and myelin.
    Brunden KR; Brown DT
    J Neurosci Res; 1990 Oct; 27(2):159-68. PubMed ID: 1701492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtle roles of neural cell adhesion molecule and myelin-associated glycoprotein during Schwann cell spiralling in P0-deficient mice.
    Carenini S; Montag D; Schachner M; Martini R
    Glia; 1999 Sep; 27(3):203-12. PubMed ID: 10457367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelin basic protein gene dosage effects in the PNS.
    Smith-Slatas C; Barbarese E
    Mol Cell Neurosci; 2000 Apr; 15(4):343-54. PubMed ID: 10845771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral myelin protein 22 kDa and protein zero: domain specific trans-interactions.
    Hasse B; Bosse F; Hanenberg H; Müller HW
    Mol Cell Neurosci; 2004 Dec; 27(4):370-8. PubMed ID: 15555916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in demyelinating peripheral neuropathies support molecular model of myelin P0-glycoprotein extracellular domain.
    Kirschner DA; Saavedra RA
    J Neurosci Res; 1994 Sep; 39(1):63-9. PubMed ID: 7528817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of myelin-specific gene expression. Relevance to CMT1.
    Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular genetics of myelination: an update.
    Lemke G
    Glia; 1993 Apr; 7(4):263-71. PubMed ID: 7686535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased P0 glycoprotein gene expression in primary and transfected rat Schwann cells after treatment with axolemma-enriched fraction.
    Knight RM; Fossom LH; Neuberger TJ; Attema BL; Tennekoon G; Bharucha V; DeVries GH
    J Neurosci Res; 1993 May; 35(1):38-45. PubMed ID: 7685396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New mutation of the myelin P0 gene in a pedigree of Charcot-Marie-Tooth neuropathy 1.
    Himoro M; Yoshikawa H; Matsui T; Mitsui Y; Takahashi M; Kaido M; Nishimura T; Sawaishi Y; Takada G; Hayasaka K
    Biochem Mol Biol Int; 1993 Sep; 31(1):169-73. PubMed ID: 7505151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies.
    Hai M; Muja N; DeVries GH; Quarles RH; Patel PI
    J Neurosci Res; 2002 Aug; 69(4):497-508. PubMed ID: 12210843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of monoclonal antibodies to the extracellular domain of P0.
    Archelos JJ; Roggenbuck K; Schneider-Schaulies J; Linington C; Toyka KV; Hartung HP
    J Neurosci Res; 1993 May; 35(1):46-53. PubMed ID: 7685397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning of cDNAs that encode the chicken P0 protein: evidence for early expression in avians.
    Barbu M
    J Neurosci Res; 1990 Jan; 25(1):143-51. PubMed ID: 1690817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis.
    Xu W; Manichella D; Jiang H; Vallat JM; Lilien J; Baron P; Scarlato G; Kamholz J; Shy ME
    J Neurosci Res; 2000 Jun; 60(6):714-24. PubMed ID: 10861783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Schwann cell phenotype by TGF-beta 1: inhibition of P0 mRNA expression and downregulation of the low affinity NGF receptor.
    Mews M; Meyer M
    Glia; 1993 Jul; 8(3):208-17. PubMed ID: 7693590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies specific to the integral membrane protein P0 of bovine peripheral nerve myelin.
    Yoshimura K; Negishi T; Kaneko A; Sakamoto Y; Kitamura K; Hosokawa T; Hamaguchi K; Nomura M
    Neurosci Res; 1996 May; 25(1):41-9. PubMed ID: 8808799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.